Lai spoke with Modern Retina about the study of PER-001, a novel therapeutic targeting the endothelin-1 receptor.
Michael Lai, MD, PhD
Advertisement
Articles by Michael Lai, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
Navigating the maze: Establishing novel endpoints for IRD trials
2
Eichenbaum Acorns: A leadership conversation with Rishi P. Singh, MD, FASRS, on advancing CME
3
Positive pediatric data emerge from the OPGx-LCA5 phase 1/2 trial of Leber congenital amaurosis type 5
4
